Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2

The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...

Descripción completa

Detalles Bibliográficos
Autores principales: Peele, K.Abraham, Kumar, Vikas, Parate, Shraddha, Srirama, Krupanidhi, Lee, Keun Woo, Venkateswarulu, T.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934671/
https://www.ncbi.nlm.nih.gov/pubmed/33684397
http://dx.doi.org/10.1016/j.xphs.2021.03.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934671/
https://www.ncbi.nlm.nih.gov/pubmed/33684397
http://dx.doi.org/10.1016/j.xphs.2021.03.004

Ejemplares similares